Suman Mbbs Kadariya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suman Mbbs Kadariya has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Faisal Chowdhury
Department of Psychiatry, Chittagong Medical College Hospital, Chattogram, Bangladesh
2 shared publications - Irfan Waheed
Department of Medicine, University of Kentucky, College of Medicine, Bowling Green, Kentucky, USA
2 shared publications - Muhammad Altaf Ahmed
Department of Medicine, University of Kentucky, College of Medicine, Bowling Green, Kentucky, USA
2 shared publications - Nisarfathima Kazimuddin
Department of Medicine, University of Kentucky, College of Medicine, Bowling Green, Kentucky, USA
2 shared publications - Rodney T. Steff
Department of Medicine, University of Kentucky, College of Medicine, Bowling Green, Kentucky, USA
2 shared publications - Tahir Muhammad Abdullah Khan
Department of Medicine, University of Kentucky, College of Medicine, Bowling Green, Kentucky, USA
2 shared publications
Latest Publications
- Open Access
- 16 June 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (7) , 4467-4475
Endobronchial Zephyr valves for bronchoscopic lung volume reduction for severe emphysema: a systematic review and meta-analysis
Background: Chronic obstructive pulmonary disease (COPD) causes permanent lung damage and is a global health issue. Bronchoscopic Lung Volume Reduction (BLVR) with Zephyr valves has increased COPD treatment choices for individuals with persistent symptoms despite maximal drug therapy. Objectives: This systematic review and meta-analysis evaluated available Zephyr valve data in severe emphysema patients. Data and methods: We searched Cochrane, PubMed, Google Scholar, Lilacs, and Science Direct extensively and included eight randomized control trials (RCTs). Results: This meta-analysis comprises 1083 patients 669 Zephyr valve-treated and 414 control. The mean difference in 6-minute walking distance was 37.53 meters (95% CI: 22.14–52.90, P < 0.001). Statistically significant improvements were also observed in FEV1 predicted percentage (mean difference: 13.64, 95% CI: 8.51–18.77, P < 0.001) and BODE index change (mean difference: −0.79, 95% CI: −1.33 to 0.26, P < 0.05), mMRC dyspnea scale (mean difference: −0.27, 95% CI: −0.55 to 0.02, P < 0.01) and residual volume (mean difference: −0.14, 95% CI: −0.64 to 0.35, P < 0.01). The quality of life measured by SGRQ also improved significantly (mean difference: −6.69, 95% CI: −9.69, −4.23, P < 0.001). While COPD exacerbation rates (OR:1.41, 95% CI: 0.87–2.30, P > 0.05) and pneumonia rates (OR: 1.72, 95% CI: 0.7–4.23, P > 0.05) were similar between valve and control groups, pneumothorax risk was significantly higher in the treatment arm (OR: 11.06, 95% CI: 4.10–29.80, P < 0.001). However, there was no significant difference in all-cause mortality between the groups (OR: 1.69; 95% CI: 0.53–5.38, P > 0.38). Conclusion: Zephyr valves may improve lung function, exercise capacity, and quality of life in patients suffering from severe emphysema. However, the increased risk of pneumothorax requires careful patient selection and rigorous post-intervention monitoring.
- 16 June 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (7) , 4467-4475
Open AccessEndobronchial Zephyr valves for bronchoscopic lung volume reduction for severe emphysema: a systematic review and meta-analysis
Background: Chronic obstructive pulmonary disease (COPD) causes permanent lung damage and is a global health issue. Bronchoscopic Lung Volume Reduction (BLVR) with Zephyr valves has increased COPD treatment choices for individuals with persistent symptoms despite maximal drug therapy. Objectives: This systematic review and meta-analysis evaluated available Zephyr valve data in severe emphysema patients. Data and methods: We searched Cochrane, PubMed, Google Scholar, Lilacs, and Science Direct extensively and included eight randomized control trials (RCTs). Results: This meta-analysis comprises 1083 patients 669 Zephyr valve-treated and 414 control. The mean difference in 6-minute walking distance was 37.53 meters (95% CI: 22.14–52.90, P < 0.001). Statistically significant improvements were also observed in FEV1 predicted percentage (mean difference: 13.64, 95% CI: 8.51–18.77, P < 0.001) and BODE index change (mean difference: −0.79, 95% CI: −1.33 to 0.26, P < 0.05), mMRC dyspnea scale (mean difference: −0.27, 95% CI: −0.55 to 0.02, P < 0.01) and residual volume (mean difference: −0.14, 95% CI: −0.64 to 0.35, P < 0.01). The quality of life measured by SGRQ also improved significantly (mean difference: −6.69, 95% CI: −9.69, −4.23, P < 0.001). While COPD exacerbation rates (OR:1.41, 95% CI: 0.87–2.30, P > 0.05) and pneumonia rates (OR: 1.72, 95% CI: 0.7–4.23, P > 0.05) were similar between valve and control groups, pneumothorax risk was significantly higher in the treatment arm (OR: 11.06, 95% CI: 4.10–29.80, P < 0.001). However, there was no significant difference in all-cause mortality between the groups (OR: 1.69; 95% CI: 0.53–5.38, P > 0.38). Conclusion: Zephyr valves may improve lung function, exercise capacity, and quality of life in patients suffering from severe emphysema. However, the increased risk of pneumothorax requires careful patient selection and rigorous post-intervention monitoring.
- Open Access
- 28 December 2024
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 53, 102161
Primary malignant melanoma of the lung; a case report and literature review
- 28 December 2024
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 53, 102161
Open AccessPrimary malignant melanoma of the lung; a case report and literature review
- Open Access
- 15 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (46) , e40510
Factors associated with severity and anatomical distribution of diabetic foot ulcer in a tertiary care hospital in Bangladesh: A cross-sectional study
Diabetic foot ulcers are characterized by disturbances in the epidermis and/or a portion of the dermis in patients with the disease. With over a million amputations performed annually, it has also emerged as one of the primary causes of lower limb amputation globally. To better understand the severity and anatomical distribution of ulcerated areas in patients with type II diabetes mellitus, this study aimed to identify the factors associated with diabetic foot ulcers (DFUs). This descriptive cross-sectional study was conducted at M Abdur Rahim Medical College Hospital in Dinajpur, Bangladesh, from July to September 2023. The study population was selected using a purposive sampling technique based on the patients’ availability during their usual and regular treatment at MARMCH. Using a Bangla questionnaire data was obtained to evaluate the DFUs, in addition to measuring blood pressure and assessing the affected area’s neurological function. The severity of the ulcer is calculated by using the Wagner grading system. Data was analyzed by using STATS v15 and chi-square was applied. A total of 113 DFU patients took part in this study. The mean age in years was 56 ± 12 (SD + mean) and the male proportion was greater (61.9%). Most of them (93.91%) were negligent about foot care and suffered from severe DFU (86.37%). The majority of respondents (57.94%) had a right foot ulcer, of which 94.50% had severe ulcers. Almost all ulcers were severe (86.14%) and measured <5 cm in diameter (69.71%). The results highlight the tremendous burden of DFUs, which can have serious consequences and substantial mental and economic effects on patients’ healthcare systems.
- 15 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (46) , e40510
Open AccessFactors associated with severity and anatomical distribution of diabetic foot ulcer in a tertiary care hospital in Bangladesh: A cross-sectional study
Diabetic foot ulcers are characterized by disturbances in the epidermis and/or a portion of the dermis in patients with the disease. With over a million amputations performed annually, it has also emerged as one of the primary causes of lower limb amputation globally. To better understand the severity and anatomical distribution of ulcerated areas in patients with type II diabetes mellitus, this study aimed to identify the factors associated with diabetic foot ulcers (DFUs). This descriptive cross-sectional study was conducted at M Abdur Rahim Medical College Hospital in Dinajpur, Bangladesh, from July to September 2023. The study population was selected using a purposive sampling technique based on the patients’ availability during their usual and regular treatment at MARMCH. Using a Bangla questionnaire data was obtained to evaluate the DFUs, in addition to measuring blood pressure and assessing the affected area’s neurological function. The severity of the ulcer is calculated by using the Wagner grading system. Data was analyzed by using STATS v15 and chi-square was applied. A total of 113 DFU patients took part in this study. The mean age in years was 56 ± 12 (SD + mean) and the male proportion was greater (61.9%). Most of them (93.91%) were negligent about foot care and suffered from severe DFU (86.37%). The majority of respondents (57.94%) had a right foot ulcer, of which 94.50% had severe ulcers. Almost all ulcers were severe (86.14%) and measured <5 cm in diameter (69.71%). The results highlight the tremendous burden of DFUs, which can have serious consequences and substantial mental and economic effects on patients’ healthcare systems.